TroponinT After Subcutaneous Cardioverter-Defibrillator Implantation

NCT03526302 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2023-03-20

No results posted yet for this study

Summary

Serum Troponin levels pre- and postoperatively will be compared in patients receiving an entirely subcutaneous cardioverter-defibrillator.

Conditions

Sponsors & Collaborators

  • Deutsches Herzzentrum Muenchen

    lead OTHER

Principal Investigators

  • Christof Kolb, MD · Deutsches Herzzentrum München

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03526302 on ClinicalTrials.gov